Medicenna Therapeutics Corp. Cash Flows From Used In Financing Activities
Medicenna Therapeutics Corp. (MDNAF) reported Cash Flows From Used In Financing Activities of CAD 24.76 million for the 3-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2023-06-27
- Medicenna Therapeutics Corp. cash flows from used in financing activities for the quarter ending 2023-03-31 was 24.76M CAD, a 538.47% increase year-over-year.
- Medicenna Therapeutics Corp. cash flows from used in financing activities for the quarter ending 2022-03-31 was 3.88M CAD, a 78.76% decline year-over-year.
- Medicenna Therapeutics Corp. cash flows from used in financing activities for the quarter ending 2021-03-31 was 18.26M CAD.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2023-03-31 | 24.76M CAD 20-F · filed 2023-06-27 | |
| 2022-03-31 | 3.88M CAD 20-F · filed 2023-06-27 | 3.88M CAD 20-F · filed 2022-06-22 |
| 2021-03-31 | 18.26M CAD 20-F · filed 2023-06-27 | 18.26M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | 40.74M CAD 20-F · filed 2022-06-22 |